BioEclipse Therapeutics INC.
Total Awards:
1
Award Value:
$7,999,689
Institution type:
For profit
Short Name:
BioEclipse Therapeutics INC.
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Dr. Pamela Reilly Contag | PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS | $7,999,689 |
| Total: $7,999,689.00 |